A Phase 4 interventional study of Lidocaine 7% + Tetracaine 7% cream in Healthy Volunteers, sponsored by Galderma R&D. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-09-02.
Sponsored by Galderma R&D (part of Galderma Group AG) · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this study is to evaluate the duration of anesthetic effect produced , Lidocaine7% + Tetracaine 7% cream when applied with 2 different application times on the face and thigh.
Subjects will have 4 target zones defined; 2 on the face and 2 on the anterior thighs. Upon inclusion into the study, subjects will have the study drug applied with a different application time to one side of the face and anterior thigh according to the randomization. After the completion of the application process, study drug on both sides of the face and on both anterior thighs will be removed by peeling.
After drug removal, the duration of anesthetic effect of the study drug will be tested using a pinprick test. Five (5) pinpricks using a 21-gauge needle will be performed at the 4 target zones (each side of the face and both anterior thighs). The pinprick test will be repeated up to 8 hours after drug removal. There will be a total of 20 post drug removal pinprick test completed.
Galderma R&D is the lead sponsor of 284 studies on the registry; 11 are open to participants now.
Of its 60 completed or terminated interventional studies of FDA-regulated products, 55 (92%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: Lidocaine 7% + Tetracaine 7% cream
Drug page: Lidocaine
Study drug will be applied with a different application time to one side of the face and anterior thigh according to the randomization list.
Duration of Anesthesia(Minutes)
Onset and end of anesthesia are evaluated by Pinprick tests. Duration of anesthesia is calculated as: difference between onset and end of anesthesia (minutes).
Time frame: From T0 (product removal) up to T8 hours after product removal
Adverse Events
Incidence of adverse events was to be reported during the study period
Time frame: During the study
31 healthy volunteers have been enrolled in one Phase I center at USA.First subject in: May 3d 2012; Last subject ou: May 26th 2012.
| Milestone | Face 2 Application Times/ Thight 2 Application Times |
|---|---|
| Started | 31 |
| Completed | 31 |
| Not completed | 0 |
Incidence of adverse events was to be reported during the study period
| participants | Lidocaine 7% + Tetracaine 7% Face - First Application Time | Lidocaine 7% + Tetracaine 7% Face - Second Application Time | Lidocaine 7% + Tetracaine 7% Thigh - First Application Time | Lidocaine 7% + Tetracaine 7% Thigh - Second Application Time |
|---|---|---|---|---|
| Adverse Events | 2 | 2 | 2 | 2 |
Onset and end of anesthesia are evaluated by Pinprick tests. Duration of anesthesia is calculated as: difference between onset and end of anesthesia (minutes).
| Minutes | Lidocaine 7% + Tetracaine 7% Face - First Application Time | Lidocaine 7% + Tetracaine 7% Face - Second Application Time | Lidocaine 7% + Tetracaine 7% Thigh - First Application Time | Lidocaine 7% + Tetracaine 7% Thigh - Second Application Time |
|---|---|---|---|---|
| Duration of Anesthesia(Minutes) | 80 (0 to 420) | 140 (0 to 480) | 0 (0 to 460) | 400 (0 to 480) |
Collected over All study period (from Baseline to end of teh study). Non-serious events are listed at a 2% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Lidocaine 7% + Tetracaine 7% | — | 0/31 (0%) | 2/31 (6.5%) |
| Event | Lidocaine 7% + Tetracaine 7% |
|---|---|
| SINUS HEADACHENervous system disorders | 1/31 |
| HEADACHENervous system disorders | 1/31 |
| DIZZINESSNervous system disorders | 1/31 |
No sample size determination as a standard sample size for this type of study is about 30 subjects.
| Age, Categorical(Participants) | Lidocaine 7% and Tetracaine 7% |
|---|---|
| <=18 years | 0 |
| Between 18 and 65 years | 29 |
| >=65 years | 2 |
| Age, Continuous(years) | Lidocaine 7% and Tetracaine 7% |
|---|---|
| Mean | 47.2 ± 1.27 |
| Sex: Female, Male(Participants) | Lidocaine 7% and Tetracaine 7% |
|---|---|
| Female | 20 |
| Male | 11 |
| Region of Enrollment(participants) | Lidocaine 7% and Tetracaine 7% |
|---|---|
| United States | 31 |
The record gives a start of May 2012, a primary completion of May 2012 and a completion of May 2012. It does not say whether these dates are actual or estimated.
Results were first posted in Sep 2013, 1 year 4 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Lidocaine